Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- Latest filing
- Aug 13, 2026
LXEO holding history
Lexeo Therapeutics, Inc. in every 13F filed by Affinity Asset Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LXEO overviewAll 13F holders of LXEOFull Q2 2026 holdings
- Shares (Q2 2026)
- 5,807,611
- Value
- $27.0M
- % of portfolio
- 1.3%
- Quarters held
- 6
- Since Q1 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 5,807,611 | $27.0M | 1.3% | +757,400+15.0% | Added | Holders |
| Q1 2026 | 5,050,211 | $29.0M | 1.7% | +1,850,211+57.8% | Added | Holders |
| Q4 2025 | 3,200,000 | $31.8M | 2.3% | −670,527−17.3% | Reduced | Holders |
| Q3 2025 | 3,870,527 | $25.7M | 2.4% | +281,172+7.8% | Added | Holders |
| Q2 2025 | 3,589,355 | $14.4M | 2.1% | +2,108,474+142.4% | Added | Holders |
| Q1 2025 | 1,480,881 | $5.14M | 0.8% | +1,480,881 | New | Holders |